These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23079391)

  • 41. Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle.
    Heading RC
    Clin Med (Lond); 2017 Apr; 17(2):132-136. PubMed ID: 28365622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: gastro-oesophageal reflux disease and psychological comorbidity.
    Mizyed I; Fass SS; Fass R
    Aliment Pharmacol Ther; 2009 Feb; 29(4):351-8. PubMed ID: 19035971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.
    Jonasson C; Wernersson B; Hoff DA; Hatlebakk JG
    Aliment Pharmacol Ther; 2013 Mar; 37(5):564-72. PubMed ID: 23289763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory gastroesophageal reflux disease: advances and treatment.
    Ates F; Francis DO; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):657-67. PubMed ID: 24745809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unsolved problems in the management of patients with gastro-oesophageal reflux disease.
    Stanghellini V; Cogliandro R; Cogliandro L; De Giorgio R; Barbara G; Corinaldesi R
    Dig Liver Dis; 2003 Dec; 35(12):843-8. PubMed ID: 14703877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastro-oesophageal reflux disease.
    Fass R; Boeckxstaens GE; El-Serag H; Rosen R; Sifrim D; Vaezi MF
    Nat Rev Dis Primers; 2021 Jul; 7(1):55. PubMed ID: 34326345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease.
    Gatta L; Vaira D; Sorrenti G; Zucchini S; Sama C; Vakil N
    Aliment Pharmacol Ther; 2007 Feb; 25(4):385-92. PubMed ID: 17269993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
    Gallusi G; Pontone S
    Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
    Gerson LB; Bonafede M; Princic N; Gregory C; Farr A; Balu S
    Aliment Pharmacol Ther; 2011 Sep; 34(5):555-67. PubMed ID: 21714794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease].
    Juhász M; Tulassay Z
    Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of gastro-oesophageal reflux disease: role of proton pump inhibitor test and upper gastro-intestinal endoscopy.
    Bianco MA; Rotondano G; Prisco A; Meucci C; Cipolletta L
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):271-5. PubMed ID: 17345931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
    Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
    Trials; 2016 Apr; 17():175. PubMed ID: 27036555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis management of gastroesophageal reflux disease in adults].
    Abbes L; Zinzindohoué F
    Rev Prat; 2016 Dec; 66(10):1086-1089. PubMed ID: 30512472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.